• Login
    View Item 
    •   Home
    • 1 Published Research and Commentary
    • Health Politics
    • View Item
    •   Home
    • 1 Published Research and Commentary
    • Health Politics
    • View Item
    Jan 23, 2021
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Browse

    All of MSFTitleAuthorsSubjectsPublisherJournalThis CollectionTitleAuthorsSubjectsPublisherJournal

    Access to Essential Drugs in Poor Countries: A Lost Battle?

    • CSV
    • RefMan
    • EndNote
    • BibTex
    • RefWorks
    Authors
    Pécoul, B
    Chirac, P
    Trouiller, P
    Pinel, J
    Affiliation
    Fondation Médecins Sans Frontières, Paris, France. office@paris.msf.org
    Issue Date
    1999-01-27
    
    Metadata
    Show full item record
    Journal
    JAMA : the Journal of the American Medical Association
    Abstract
    Drugs offer a simple, cost-effective solution to many health problems, provided they are available, affordable, and properly used. However, effective treatment is lacking in poor countries for many diseases, including African trypanosomiasis, Shigella dysentery, leishmaniasis, tuberculosis, and bacterial meningitis. Treatment may be precluded because no effective drug exists, it is too expensive, or it has been withdrawn from the market. Moreover, research and development in tropical diseases have come to a near standstill. This article focuses on the problems of access to quality drugs for the treatment of diseases that predominantly affect the developing world: (1) poor-quality and counterfeit drugs; (2) lack of availability of essential drugs due to fluctuating production or prohibitive cost; (3) need to develop field-based drug research to determine optimum utilization and remotivate research and development for new drugs for the developing world; and (4) potential consequences of recent World Trade Organization agreements on the availability of old and new drugs. These problems are not independent and unrelated but are a result of the fundamental nature of the pharmaceutical market and the way it is regulated.
    URI
    http://hdl.handle.net/10144/18924
    PubMed ID
    9929090
    Additional Links
    http://jama.ama-assn.org/cgi/content/full/281/4/361?ijkey=v7ANi6A7kiVu2&keytype=ref&siteid=amajnls
    Language
    en
    Description
    To access this article, click on "Additional Links"
    ISSN
    0098-7484
    Collections
    Health Politics

    entitlement

    Related articles

    • Trade, TRIPS, and pharmaceuticals.
    • Authors: Smith RD, Correa C, Oh C
    • Issue date: 2009 Feb 21
    • Spurious and counterfeit drugs: a growing industry in the developing world.
    • Authors: Gautam CS, Utreja A, Singal GL
    • Issue date: 2009 May
    • [Patents and availability of essential drugs].
    • Authors: Carné X
    • Issue date: 2007 Nov 3
    • Can Brazil play a more important role in global tuberculosis drug production? An assessment of current capacity and challenges.
    • Authors: Gemal A, Keravec J, Menezes A, Trajman A
    • Issue date: 2013 Mar 27
    • TRIPS, pharmaceutical patents, and access to essential medicines: a long way from Seattle to Doha.
    • Authors: 't Hoen E
    • Issue date: 2002 Spring
    DSpace software (copyright © 2002 - 2021)  DuraSpace
    Quick Guide | Contact Us
    Open Repository is a service operated by 
    Atmire NV
     

    Export search results

    The export option will allow you to export the current search results of the entered query to a file. Different formats are available for download. To export the items, click on the button corresponding with the preferred download format.

    By default, clicking on the export buttons will result in a download of the allowed maximum amount of items.

    To select a subset of the search results, click "Selective Export" button and make a selection of the items you want to export. The amount of items that can be exported at once is similarly restricted as the full export.

    After making a selection, click one of the export format buttons. The amount of items that will be exported is indicated in the bubble next to export format.